Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-075-1 | CAS number: 38668-48-3
Toxicological information
Skin sensitisation
Currently viewing:
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11.09.2001-12.10.2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and OECD guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MAFF Testing Guideline of 12 Nosan No. 1847
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- testing lab.
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was conducted before LLNA guideline was published.
Test material
- Reference substance name:
- 1,1'-(p-tolylimino)dipropan-2-ol
- EC Number:
- 254-075-1
- EC Name:
- 1,1'-(p-tolylimino)dipropan-2-ol
- Cas Number:
- 38668-48-3
- Molecular formula:
- C13H21NO2
- IUPAC Name:
- 1,1'-(p-tolylimino)dipropan-2-ol
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Hsd Poc: DH
- Sex:
- female
- Details on test animals and environmental conditions:
- The animals were identified via ear tattoo.
Age of the animals at start of the study: ca. 6 weeks
Body weight range at start of the study: 323 - 385 g
The guinea pigs were housed in fully air-conditioned rooms with a temperature in the range of 20 - 24°C
Relative humidity of 30 - 70 %
The day/night rhythm was 12 h dark and 12 h light
Five animals per cage (type stainless steel wire mesh cages with plastic-coated grating)
A standardized laboratory diet and tap water were available ad libitum
Source Harlan Winkelmann GmbH, Borchen, FRG
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Lutrol E 400 or olive oil
- Concentration / amount:
- intradermal induction: 0.1 % in olive oil
epicutaneous induction: 50 % test substance preparation in Lutrol E 400
challenge: 25 % test substance preparation in Lutrol E 400
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Lutrol E 400 or olive oil
- Concentration / amount:
- intradermal induction: 0.1 % in olive oil
epicutaneous induction: 50 % test substance preparation in Lutrol E 400
challenge: 25 % test substance preparation in Lutrol E 400
- No. of animals per dose:
- 5 control group
10 test group - Details on study design:
- Induction
Intradermal induction:
6 intradermal injections in groups of two per animal were applied to each animal
side of application: neck region
Injections for the control groups:
A) front row: 2 injections each of 0.1 mL Freund's adjuvant without test substance
emulsified with 0.9 % aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 mL of the undiluted vehicle
C) back row: 2 injections each of 0.1 mL of a 50 % formulation of the vehicle without
test substance emulsified with Freund's adjuvant* / 0.9 % aqueous NaCI-solution 1 :1
Injection for the test group:
A) front row: 2 injections each of 0.1 mL Freund's adjuvant* without test substance
emulsified with 0.9 % aqueous NaCI-solution in a ratio of 1 : 1
B) middle row: 2 injections each of 0.1 mL of a test substance formulation in an
appropriate vehicle at the selected concentration
C) back row: 2 injections each of 0.1 mL Freund's adjuvant* / 0.9 % aqueous
NaCI-solution 1 : 1 with test substance at the selected concentration.
Reading: 24 h after the beginning of application
Epicutaneous induction:
one week after intradermal induction
test group: 1 mL of the test substance formulation/animal
control group: treated analogously to the test group but only with the vehicle without the test substance
Duration of exposure: 48 hours
Side of application: neck region, same area as in the case of the previous intradermal application
Reading: 48 h after the beginning of application
Challenge:
14 days after the epicutaneous induction
0.5 mL of the test substance formulation was applied to each animal
test group and control group 1 were treated with the substance formulation. Additionally, Lutrol E 400 was applied as a vehicle control. Control group 2 only received Lutrol E 400.
Duration of exposure: 24 hours
Site of application: intact flank
Reading: 24 h and 48 h after the removal of the patch - Positive control substance(s):
- yes
- Remarks:
- A positive control with a known sensitizer was not included in this study. However, a separate study was performed twice a year in the Iaboratory using Alpha-Hexylcinnamaldehyde.
Results and discussion
- Positive control results:
- The positive controls with Alpha-Hexylcinnamaldehyde techn. 85% showed that the test system was able to detect sensitizing compounds under the Iaboratory conditions chosen.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- discrete or patchy erythema
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: discrete or patchy erythema.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
Any other information on results incl. tables
The intradermal induction caused moderate and confluent erythema and swelling or intense erythema and swelling at the injection sites of the test substance preparation in all test group animals. After the epicutaneous induction incrustation, partially open (caused by the intradermal induction) could be observed in addition to moderate and confluent erythema and swelling in all test group animals.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
